Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2014

View Archived Issues

Researchers describe mechanism of action of ProHema

Acucela completes enrollment in SEATTLE study of emixustat

Targeting the self-renewal of cancer-initiating cells as a new approach for colorectal cancer

Janssen Pharmaceutica designs new agents for pain

Novel SYK inhibitors synthesized at Novartis

Proteostasis Therapeutics and Cystic Fibrosis Foundation Therapeutics extend collaboration

Cellectar Biosciences begins phase II imaging trial of [124I]CLR-1404

Genticel begins phase II trial in women with high-risk HPV

New milestone reached in Genfit and Sanofi's research collaboration

Viriom begins new program for chronic hepatitis B

International Stem Cell reports interim data from stem cell primate study for Parkinson's disease

Astex receives milestone payment as LEE-011 enters phase III trial

Eisai and Biogen Idec to collaborate in Alzheimer's disease

High 12-week sustained virological response rates in PEARL III study

Vaginal dapivirine effectively protects against HIV challenge

Novartis reports novel SMN modulators for spinal muscular atrophy

New KOR-1 antagonists patented by the Scripps Research Institute

FDA accepts additional Lymphoseek supplemental NDA for review

Kamada initiates phase II/III trials with intravenous Glassia for the treatment of type 1 diabetes

FDA issues complete response letter for empagliflozin

Next-generation sequencing for a rare cancer

Janssen Biotech to begin phase III study of daratumumab in multiple myeloma

FDA grants fast track designation to Tekmira's TKM-Ebola

Regulus Therapeutics initiates phase I study of RG-101

Agenus selects modulator antibodies to advance into preclinical development

iCo Therapeutics updates progress of iDEAL study of iCo-007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Sumitomo’s DSP-3456 exerts antidepressant-like effects
BioWorld Science
About one-third of patients with major depressive disorder (MDD) are treatment resistant. Ketamine is very effective in treatment-resistant depression, but it is...